Print

Print


-see ADVERSE EFFECTS OF STATIN AS WEAPONS AGAINST BRITISH MEDICAL JOURNAL
http://www.bmj.com/content/348/bmj.g3306?tab=responses

El 21/05/2014 16:20, Juan Gérvas escribió:
> -thanks Lejla
> -indeed the BMJ has being a rock helping physicians to work well
> -but about statins side effects now we have many "Doctor Cholesterol"
> -they say/writte that "statins have no side effects" or "give statins 
> to all over-40" or "they should be made available for sale over the 
> counter and without the need for a prescription" or "statins have been 
> around for 25 years, so we know the long-term results", etc.
> -most scientifics answer with questions around clinical trials and 
> theway they hide adverse events
> -but no one even remember hundreds of people that have died because 
> rhabdomyolisis a little more than ten years ago, with cerivastatin 
> (having no single death during the clinical trials) 
> http://www.healthyskepticism.org/global/news/int/hsint2002-06 
> <http://www.healthyskepticism.org/global/news/int/hsint2002-06>
> -in general, the statins mortality risk from fatal rhabdomyolysis is 
> approximately 0.3 per 100,000 person-years 
> http://www.sciencedirect.com/science/article/pii/S0002914905021508 
> <http://www.sciencedirect.com/science/article/pii/S0002914905021508> 
> so we can expect in the UK (when 12 millions under statins treatment 
> http://www.telegraph.co.uk/health/healthnews/10632047/Statins-12-million-Brits-will-be-advised-to-take-cholesterol-lowering-drug.html 
> ) 36 deaths per year
> -Dr Cholesterol set the agenda "statins have no side effects" and "no 
> debate about the lack of effectiveness of statins in primary prevention"
> -behind the agenda, no doubt, is the objetive to weak BMJ position and 
> its editor role
> -un saludo
> -juan gérvas
>
> El 21/05/2014 15:38, Lejla Halilovic escribió:
>> Great and timely article on every front, Juan: appropriate and 
>> informed patient treatments, journal independence, clinical data 
>> transparency, balanced and fair scientific debates.
>>
>> Patients around the world and we all stand a lot to lose if BMJ 
>> succumbs to these unreasonable (and might I add /unknightly/) pressures.
>>
>> Recently, Swedish Medical Association joined AllTrials, which is 
>> promising. Physicians around the globe need to understand these 
>> important transparency debates.
>>
>> BMJ's motto is: /Helping doctors make better decisions./ It seems we 
>> all now need to/help BMJ help doctors make better decisions.
>> /
>> I encourage all on this list, especially physicians, to join the 
>> debate and voice their opinions in form of rapid responses to BMJ's 
>> recent editorial <http://www.bmj.com/content/348/bmj.g3306>. Read 
>> responses published thus far here 
>> <http://www.bmj.com/content/348/bmj.g3306?tab=responses>.
>>
>> Sincerely,
>>
>> Lejla
>>
>>
>>
>> On Wed, May 21, 2014 at 6:42 AM, Juan Gérvas <[log in to unmask] 
>> <mailto:[log in to unmask]>> wrote:
>>
>>     Adverse effects of statin as weapons against British Medical Journal.
>>     SUMMARY
>>     It appears that the adverse effects of statins are being used as
>>     a smokescreen to avoid the debate over its lack of effect in
>>     primary prevention. The ultimate intention is likely to change
>>     the line of independence of the British Medical Journal, to
>>     change its editor and to promote industrial interests.
>>     (attached, with references and in
>>     http://www.nogracias.eu/2014/05/21/adverse-effects-statin-weapons-british-medical-journal/
>>
>>
>>
>>     ---
>>     Este mensaje no contiene virus ni malware porque la protección de
>>     avast! Antivirus está activa.
>>     http://www.avast.com
>>
>>
>



---
Este mensaje no contiene virus ni malware porque la protección de avast! Antivirus está activa.
http://www.avast.com